Catalyst Pharmaceutical Partners, Inc. Begins Enrollment For U.S. Phase II Clinical T [Archive] - Recovery Works Alcoholism and Addiction Forums

RSS Bot

07-01-2008, 04:37 AM

Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX), a biopharmaceutical company that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction and obsessive compulsive disorders, announced that it has begun enrollment for its randomized, double-blind, placebo-controlled U.S. Phase II clinical trial evaluating CPP-109 for the treatment of patients addicted to methamphetamine.

More... (http://www.medicalnewstoday.com/articles/113358.php)